Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continuous Alloreactive T Cell Depletion and Regulatory T Cell Expansion for the Treatment of Steroid-refractory or Dependent Chronic GVHD

NCT02519816 is registered in ClinicalTrials.gov with daphne brockington as lead sponsor.

NCT NCT02519816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02519816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continuous Alloreactive T Cell Depletion and Regulatory T Cell Expansion for the Treatment of Steroid-refractory or Dependent Chronic GVHD
Lead sponsor
daphne brockington
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2016
Completion date
January 1, 2020
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic gvhd after hct for cancer or immune disease